Antitumor efficacy and intratumoral distribution of SN-38 from polymeric depots in brain tumor model

Exp Biol Med (Maywood). 2015 Dec;240(12):1640-7. doi: 10.1177/1535370215590819. Epub 2015 Jun 16.

Abstract

We investigate antitumor efficacy and 2D and 3D intratumoral distribution of 7-ethyl-10-hydroxycamptothecin (SN-38) from polymeric depots inside U-87MG xenograft tumor model in nude mice. Results showed that polymeric depots could be used to administer and controlled release of a large amount of SN-38 directly to the brain tumor model. SN-38 released from depots suppressed tumor growth, where the extent of suppression greatly depended on doses and the number of depot injections. Tumor suppression of SN-38 from depots was three-fold higher in animals which received double injections of depots at high dose (9.7 mg of SN-38) compared to single injection (2.2 mg). H&E staining of tumor sections showed that the area of tumor cell death/survival of the former group was two-fold higher than those of the latter group. Fluorescence imaging based on self-fluorescent property of SN-38 was used to evaluate the intratumoral distribution of this drug compared to histological results. The linear correlation between fluorescence intensity and the amount of SN-38 allowed quantitative determination of SN-38 in tumor tissues. Results clearly showed direct correlation between the amount of SN-38 in tumor sections and cancer cell death. Moreover, 3D reconstruction representing the distribution of SN-38 in tumors was obtained. Results from this study suggest the rationale for intratumoral drug administration and release of drugs inside tumor, which is necessary to design drug delivery systems with efficient antitumor activity.

Keywords: Biodegradable polymer; SN-38; brain tumor model; drug delivery system; intratumoral.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Agents, Phytogenic / analysis
  • Antineoplastic Agents, Phytogenic / pharmacokinetics
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Brain Neoplasms / chemistry
  • Brain Neoplasms / drug therapy*
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives*
  • Camptothecin / analysis
  • Camptothecin / pharmacokinetics
  • Camptothecin / therapeutic use
  • Delayed-Action Preparations
  • Dose-Response Relationship, Drug
  • Drug Delivery Systems
  • Female
  • Irinotecan
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Treatment Outcome
  • Xenograft Model Antitumor Assays

Substances

  • Antineoplastic Agents, Phytogenic
  • Delayed-Action Preparations
  • Irinotecan
  • Camptothecin